DIABETES-MELLITUS AND HYPERTENSION

被引:460
作者
EPSTEIN, M
SOWERS, JR
机构
[1] UNIV MIAMI, SCH MED, DEPT MED, MIAMI, FL 33152 USA
[2] WAYNE STATE UNIV, SCH MED, DETROIT, MI 48201 USA
[3] DEPT VET AFFAIRS MED CTR, MED SERV, MIAMI, FL USA
关键词
DIABETES-MELLITUS; DIABETIC NEPHROPATHY; ESSENTIAL HYPERTENSION; KIDNEY FAILURE;
D O I
10.1161/01.HYP.19.5.403
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Diabetes mellitus and hypertension are common diseases that coexist at a greater frequency than chance alone would predict. Hypertension in the diabetic individual markedly increases the risk and accelerates the course of cardiac disease, peripheral vascular disease, stroke, retinopathy, and nephropathy. Our understanding of the factors that markedly increase the frequency of hypertension in the diabetic individual remains incomplete. Diabetic nephropathy is an important factor involved in the development of hypertension in diabetics, particularly type I patients. However, the etiology of hypertension in the majority of diabetic patients cannot be explained by underlying renal disease and remains "essential" in nature. The hallmark of hypertension in type I and type II diabetics appears to be increased peripheral vascular resistance. Increased exchangeable sodium may also play a role in the pathogenesis of blood pressure in diabetics. There is increasing evidence that insulin resistance/hyperinsulinemia may play a key role in the pathogenesis of hypertension in both subtle and overt abnormalities of carbohydrate metabolism. Population studies suggest that elevated insulin levels, which often occurs in type II diabetes mellitus, is an independent risk factor for cardiovascular disease. Other cardiovascular risk factors in diabetic individuals include abnormalities of lipid metabolism, platelet function, and clotting factors. The goal of antihypertensive therapy in the patient with coexistent diabetes is to reduce the inordinate cardiovascular risk as well as lowering blood pressure.
引用
收藏
页码:403 / 418
页数:16
相关论文
共 278 条
  • [1] DIABETES AND THE RISK OF STROKE - THE HONOLULU-HEART-PROGRAM
    ABBOTT, RD
    DONAHUE, RP
    MACMAHON, SW
    REED, DM
    YANO, K
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (07): : 949 - 952
  • [2] ANDERSEN AR, 1983, DIABETOLOGIA, V25, P496
  • [3] CAPILLARY SUPPLY OF QUADRICEPS FEMORIS MUSCLE OF MAN - ADAPTIVE RESPONSE TO EXERCISE
    ANDERSEN, P
    HENRIKSSON, J
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 1977, 270 (03): : 677 - &
  • [4] ANDERSEN P, 1985, AM J PHYSIOL, V248, pE567
  • [5] HYPERINSULINEMIA PRODUCES BOTH SYMPATHETIC NEURAL ACTIVATION AND VASODILATION IN NORMAL HUMANS
    ANDERSON, EA
    HOFFMAN, RP
    BALON, TW
    SINKEY, CA
    MARK, AL
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (06) : 2246 - 2252
  • [6] PATHOGENESIS OF DIABETIC GLOMERULOPATHY - HEMODYNAMIC CONSIDERATIONS
    ANDERSON, S
    BRENNER, BM
    [J]. DIABETES-METABOLISM REVIEWS, 1988, 4 (02): : 163 - 177
  • [7] INFLUENCE OF ANTIHYPERTENSIVE THERAPY ON DEVELOPMENT AND PROGRESSION OF DIABETIC GLOMERULOPATHY
    ANDERSON, S
    BRENNER, BM
    [J]. DIABETES CARE, 1988, 11 (10) : 846 - 849
  • [8] THE NA+/H+ ANTIPORT, CYTOSOLIC FREE CA-2+, AND ESSENTIAL-HYPERTENSION - A HYPOTHESIS
    AVIV, A
    LIVNE, A
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 1988, 1 (04) : 410 - 413
  • [9] RENAL EFFECTS OF NICARDIPINE, A CALCIUM ENTRY BLOCKER, IN HYPERTENSIVE TYPE-II DIABETIC-PATIENTS WITH NEPHROPATHY
    BABA, T
    ISHIZAKI, T
    IDO, Y
    AOYAGI, K
    MURABAYASHI, S
    TAKEBE, K
    [J]. DIABETES, 1986, 35 (11) : 1206 - 1214
  • [10] BABA T, 1989, DIABETOLOGIA, V32, P40